Hamamatsu Photonics
VC Fund
Hamamatsu, Japan
Hamamatsu Photonics is a VC fund in Hamamatsu focused on Biotechnology and Health Care. coinbase number Hamamatsu Photonics, a world-leading manufacturer of optoelectronic components and systems, will be displaying at the Wearable Technology Show innovative detectors and emitters suitable for measuring heart rate, skin moisture and distance. Devices are mounted in miniature packages and have low power consumption making them highlysuitable for wearable products
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Hamamatsu Photonics invests in
Stages Hamamatsu Photonics invests in
Countries Hamamatsu Photonics invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $184k–$11M
Investment Focus
Industry
- Biotechnology 3 (50%)
- Health Care 2 (33%)
- Health Diagnostics 2 (33%)
- B2B 1 (17%)
- Medical 1 (17%)
Stage
- Seed 3 (50%)
- Series B 1 (17%)
- Corporate Round 1 (17%)
- Convertible Note 1 (17%)
Country
- United States 2 (33%)
- Japan 1 (17%)
- Belgium 1 (17%)
- Finland 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Mitsuharu Miwa
Researcher
|
Researcher | Total investments: 2 | Find email | |
Adnan Quazi
Account Manager/Development
|
Account Manager/Development | Total investments: 0 | Find email | |
|
Akira Hiruma
Chairman
|
Chairman | Total investments: 1 | Find email | |
Craige Palmer
General Sales Manager
|
General Sales Manager | Total investments: 0 | Find email | |
Heihachiro Horiuchi
Founder
|
Founder | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood. | $10.7M / Seed / Sep 05, 2023 | ||
| NLM Photonics is a pioneering photonics company developing computing and networking solutions and devices. | $220K / Convertible Note / Jun 14, 2022 | ||
| Armonica Technologies derives its name from prolific innovator Benjamin Franklin’s favorite invention, The Glass Armonica. Armonica Technologies is an early stage medtech company focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications. The Company’s technology is based upon a portfolio ofpatented and patent pending technologies licensed from STC.UNM. | $2M / Series B / Oct 18, 2021 | ||
| Nanotis is a company which Solve various problems in infectious disease tests such as influenza. | $184K / Seed / Apr 15, 2021 | ||
| Comptek solutions offers a novel passivation technology for compound semiconductor devices.The efficiency, performance and reliability of MicroLEDs, lasers, detectors or power electronic modules, is limited due to teh aggressive oxidation of the materials they use. This oxidation results in big amounts of defects at atomic level that will make thedevices to be less power efficient, and also to have big reliability issues, leading to low manufacturing yields, thus high costs. Our break-thru quantum technology, Kontrox(TM), boosts the performance of devices and makes their manufacturing process easier. It has proven to increase performance of e.g. uLEDs by 250%, which means reduction of power consumption by 90 times. Kontrox is applicable to a wide variety of compound semiconductor materials and applications including optoelectronics, power electronics and RF applications.The company was awarded in 2018 with a SME phase I grant by the EU under the Horizon2020 program. In 2020 Comptek Solutions is shortlisted as one of only 2 world top semiconductor- based spinoff companies in the inaugural Spinoff Prize competition organized by the prestigious Nature Research. | $572K / Seed / Dec 30, 2018 | ||
| Nanotis is a company which Solve various problems in infectious disease tests such as influenza. | $402.4K / Corporate Round / Oct 15, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Hamamatsu Photonics invest in?
Hamamatsu Photonics invests primarily in Biotechnology, Health Care and Health Diagnostics startups, most often at Seed and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Hamamatsu Photonics invest in?
Hamamatsu Photonics typically joins rounds of $184k–$11M at Seed. These are whole funding-round sizes, not Hamamatsu Photonics's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Hamamatsu Photonics took part in.
How do I contact Hamamatsu Photonics?
Public channels for Hamamatsu Photonics include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Hamamatsu Photonics?
The team at Hamamatsu Photonics includes Mitsuharu Miwa (Researcher), Adnan Quazi (Account Manager/Development) and Akira Hiruma (Chairman), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
